QQQ   422.29 (-0.26%)
AAPL   165.34 (-1.02%)
MSFT   402.57 (-0.42%)
META   496.13 (-1.13%)
GOOGL   154.73 (-0.82%)
AMZN   178.14 (-0.60%)
TSLA   148.91 (-0.68%)
NVDA   838.34 (-0.99%)
AMD   153.36 (-1.11%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.33 (+0.00%)
F   12.16 (+0.83%)
MU   109.70 (-1.99%)
GE   152.96 (+0.01%)
CGC   8.22 (+4.98%)
DIS   112.00 (-0.38%)
AMC   3.01 (+3.08%)
PFE   25.47 (+0.32%)
PYPL   62.13 (+0.05%)
XOM   119.48 (+0.81%)
QQQ   422.29 (-0.26%)
AAPL   165.34 (-1.02%)
MSFT   402.57 (-0.42%)
META   496.13 (-1.13%)
GOOGL   154.73 (-0.82%)
AMZN   178.14 (-0.60%)
TSLA   148.91 (-0.68%)
NVDA   838.34 (-0.99%)
AMD   153.36 (-1.11%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.33 (+0.00%)
F   12.16 (+0.83%)
MU   109.70 (-1.99%)
GE   152.96 (+0.01%)
CGC   8.22 (+4.98%)
DIS   112.00 (-0.38%)
AMC   3.01 (+3.08%)
PFE   25.47 (+0.32%)
PYPL   62.13 (+0.05%)
XOM   119.48 (+0.81%)
QQQ   422.29 (-0.26%)
AAPL   165.34 (-1.02%)
MSFT   402.57 (-0.42%)
META   496.13 (-1.13%)
GOOGL   154.73 (-0.82%)
AMZN   178.14 (-0.60%)
TSLA   148.91 (-0.68%)
NVDA   838.34 (-0.99%)
AMD   153.36 (-1.11%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.33 (+0.00%)
F   12.16 (+0.83%)
MU   109.70 (-1.99%)
GE   152.96 (+0.01%)
CGC   8.22 (+4.98%)
DIS   112.00 (-0.38%)
AMC   3.01 (+3.08%)
PFE   25.47 (+0.32%)
PYPL   62.13 (+0.05%)
XOM   119.48 (+0.81%)
QQQ   422.29 (-0.26%)
AAPL   165.34 (-1.02%)
MSFT   402.57 (-0.42%)
META   496.13 (-1.13%)
GOOGL   154.73 (-0.82%)
AMZN   178.14 (-0.60%)
TSLA   148.91 (-0.68%)
NVDA   838.34 (-0.99%)
AMD   153.36 (-1.11%)
NIO   3.87 (-3.25%)
BABA   68.69 (-0.28%)
T   16.33 (+0.00%)
F   12.16 (+0.83%)
MU   109.70 (-1.99%)
GE   152.96 (+0.01%)
CGC   8.22 (+4.98%)
DIS   112.00 (-0.38%)
AMC   3.01 (+3.08%)
PFE   25.47 (+0.32%)
PYPL   62.13 (+0.05%)
XOM   119.48 (+0.81%)
NASDAQ:FONR

FONAR (FONR) Stock Price, News & Analysis

$16.82
+0.30 (+1.82%)
(As of 04/18/2024 ET)
Today's Range
$16.50
$17.09
50-Day Range
$16.52
$23.24
52-Week Range
$12.13
$24.05
Volume
19,269 shs
Average Volume
17,408 shs
Market Capitalization
$106.47 million
P/E Ratio
9.14
Dividend Yield
N/A
Price Target
N/A
FONR stock logo

About FONAR Stock (NASDAQ:FONR)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

FONR Stock Price History

FONR Stock News Headlines

New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Fonar Corp.
Fonar: Fiscal Q2 Earnings Snapshot
I’m officially sounding the alarm.
AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.
Fonar Corp FONR
2024 Strategies: Buy or Hold for 3 Medical Stocks?
Holiday Outlook: 3 Medical Stocks to Consider Buying
Fonar GAAP EPS of $0.59, revenue of $25.84M
Pleasing Signs As A Number Of Insiders Buy FONAR Stock
Back Into FONAR Corporation
Fonar Shares Drop on Volume Spike
See More Headlines
Receive FONR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for FONAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
4/19/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:FONR
Employees
561
Year Founded
N/A

Profitability

Net Income
$9.38 million
Pretax Margin
19.92%

Debt

Sales & Book Value

Annual Sales
$98.64 million
Cash Flow
$2.83 per share
Book Value
$23.07 per share

Miscellaneous

Free Float
5,785,000
Market Cap
$106.50 million
Optionable
Not Optionable
Beta
1.12
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

FONR Stock Analysis - Frequently Asked Questions

How have FONR shares performed in 2024?

FONAR's stock was trading at $19.56 on January 1st, 2024. Since then, FONR shares have decreased by 14.0% and is now trading at $16.8250.
View the best growth stocks for 2024 here
.

Are investors shorting FONAR?

FONAR saw a decrease in short interest in March. As of March 31st, there was short interest totaling 8,500 shares, a decrease of 14.1% from the March 15th total of 9,900 shares. Based on an average daily volume of 19,000 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.1% of the company's shares are sold short.
View FONAR's Short Interest
.

When is FONAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our FONR earnings forecast
.

How were FONAR's earnings last quarter?

FONAR Co. (NASDAQ:FONR) announced its earnings results on Wednesday, February, 14th. The medical equipment provider reported $0.54 earnings per share for the quarter. The medical equipment provider had revenue of $25.39 million for the quarter. FONAR had a net margin of 12.63% and a trailing twelve-month return on equity of 8.47%.

What other stocks do shareholders of FONAR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FONAR investors own include Gilead Sciences (GILD), Amarin (AMRN), CRISPR Therapeutics (CRSP), Exelixis (EXEL), Pfizer (PFE), Bausch Health Companies (BHC), Incyte (INCY), Jazz Pharmaceuticals (JAZZ), Lannett (LCI) and Madrigal Pharmaceuticals (MDGL).

How do I buy shares of FONAR?

Shares of FONR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FONR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners